<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04243980</url>
  </required_header>
  <id_info>
    <org_study_id>EMC-19-0100</org_study_id>
    <nct_id>NCT04243980</nct_id>
  </id_info>
  <brief_title>Anatomical Femoral Stem in Total Hip Arthroplasty</brief_title>
  <acronym>THR</acronym>
  <official_title>Short Term Results of Short Anatomical Femoral Stem in Total Hip Arthroplasty - Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HaEmek Medical Center, Israel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HaEmek Medical Center, Israel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A study that detect the femoral anteversion after total hip arthroplasty using short
      anatomical femoral stem compared to the contrast side
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2020</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Femoral anteversion</measure>
    <time_frame>Post-Operatively, through study completion, an average of 2 years</time_frame>
    <description>comparing femoral anteversion after THR using CT scan</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Score</measure>
    <time_frame>6 weeks, 3 month, 6 month post-operative</time_frame>
    <description>The HHS is a physician-completed instrument that consists of subscales for pain severity (1 item, 0-44 points), function (7 items, 0-47 points), absence of deformity (1 item, 0-4 points), and range of motion (2 items, 0-5 points).
Where a score &lt; 70 indicating a poor result and those of 90-100 indicating an excellent result</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Patient Compliance</condition>
  <condition>Patient Satisfaction</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Patients after total hip arthroplasty with short femoral stem</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Short anatomical femoral stem in THR</intervention_name>
    <description>Patients with osteoarthritis after total hip arthroplasty</description>
    <arm_group_label>Group 1</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients aged 18 - 90 who had THR as an elective surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18-90

          -  patients who had THR as an elective surgery

          -  patients who had THR with short femoral anatomical stem

        Exclusion Criteria:

          -  severe osteoporosis with Dorr C classification

          -  s/p bilateral hip arthroplasty

          -  non-complaint patients

          -  revision surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Raja Hakim, M.D.</last_name>
    <phone>00972546612251</phone>
    <email>raja.hakim@icloud.com</email>
  </overall_contact>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 23, 2020</study_first_submitted>
  <study_first_submitted_qc>January 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2020</study_first_posted>
  <last_update_submitted>January 26, 2020</last_update_submitted>
  <last_update_submitted_qc>January 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>HaEmek Medical Center, Israel</investigator_affiliation>
    <investigator_full_name>Raja Hakim</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

